Find your next paid study

National Cancer Institute (NCI)NCT03739814

~$75 – $1,800

Actual pay is set by the research site.

Phase 3

A Phase 3, Multicenter, Prospective Open-Label Study of the Diagnostic Performance of [¹⁸F]FAPI-74 PET/CT for the Detection of Metastatic Disease in Adults With Gastric or Esophageal Cancer

This is a multi-site, open-label, non-randomized, single dose study to assess the clinical utility of \[¹⁸F\]FAPI-74 PET/CT in the detection of metastatic dise…

Esophageal CancerGastric Cancer (GC)Gastroesophageal Junction

~$50 – $2,250

Actual pay is set by the research site.

SOFIENCT07217704

An Ambispective Safety and Effectiveness Evaluation of OsteoFlo HydroFiber

The goal of this observational, ambispective study is to collect real world patient outcomes to characterize the safety and effectiveness of OsteoFlo HydroFibe…

OsteoFlo HydroFiber

~$10 – $1,050

Actual pay is set by the research site.

SurGenTec LLCNCT07784673

Phase 3

An Interventional, Open-Label, Randomized, Multicenter, Phase 3 Study of PF-07248144 Plus Fulvestrant Compared to Investigator's Choice of Therapy in Adult Participants With Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Cancer Whose Disease Progressed After Prior CDK4/6 Inhibitor-based Therapy

The purpose of this study is to learn about the safety and effects of the study medicine PF-07248144 when given along with fulvestrant for the possible treatme…

Breast Cancer

~$50 – $2,250

Actual pay is set by the research site.

PfizerNCT07062965

Postpartum ComplicationPostpartumPTSD+6 more

Postpartum Care in the NICU (PeliCaN) for Maternal Wellbeing and Breastfeeding

Parents of infants in the neonatal intensive care unit (NICU) face unique barriers to long-term breastfeeding and lactation. The physical and emotional demands…

Children's Hospital of PhiladelphiaNCT07881731

Actual pay is set by the research site.

Feasibility of the Investigational Nellcor™ Investigational Device During Non-Motion and Walking Motion Conditions in Adult Volunteers

To examine pulse rate and blood oxygen saturation accuracy of the Nellcor™ Investigational Device during non-motion and walking motion conditions in a diverse …

Oxygen Saturation

Medtronic - MITGNCT07234279

~$10 – $1,125

Actual pay is set by the research site.

Phase 1

A Two-Part, Phase 1, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and WISPER Target Engagement of HTX-001 in Adult Healthy Participants (Part 1) and in Adult Participants With Nonobstructive Hypertrophic Cardiomyopathy (Part 2)

The purpose of this study is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of HTX-001 in human adult participants.

Nonobstructive Hypertrophic Cardiomyopathy

Haya Therapeutics, Inc.NCT07867288

~$500 – $10,500

Actual pay is set by the research site.

Phase 1

A Phase 1b/2, Open-label, Multi-center Study to Evaluate the Anti-cancer Activity, Safety and Tolerability of GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig [T-CELL-Redirecting Agent Targeting Human Kallikrein 2 (KLK2)] in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Who Progressed on Previous Novel Hormonal Therapy (NHT) (JET-201)

The purpose of this clinical trial is to evaluate the safety, tolerability, and preliminary anti-cancer activity of GI-102 in combination with pasritamig in ad…

Metastatic Castration-resistant Prostate Cancer (mCRPC)

GI Innovation, Inc.NCT07871435

~$150 – $4,200

Actual pay is set by the research site.

Heart Failure With Preserved Ejection Fraction

A Prospective Randomized Unblinded Study of Ketogenetic Versus Mixed Diet on Exercise Tolerance in Subjects With the Metabolic Phenotype of Heart Failure With Preserved Ejection Fraction

This study is being done to evaluate the effects of a low carbohydrate ketogenic diet (KD) versus a low-fat diet (MD) on exercise tolerance in participants wit…

Ohio State UniversityNCT06081543

Actual pay is set by the research site.

Phase 2

Involved-Station, Intensity-Modulated Post-Operative Radiation Therapy (I²-PORT) for Resected Non-Small Cell Lung Cancer With Residual Mediastinal Adenopathy After Neoadjuvant Therapy (ypN2)

This phase II trial compares the effect of intensity-modulated post-operative radiation therapy (I²-PORT) followed by standard of care therapy (chemotherapy or…

Lung Non-Small Cell Carcinoma

Alliance for Clinical Trials in OncologyNCT07293247

~$75 – $2,000

Actual pay is set by the research site.

Personalized Risk Assessment of Seizures Sensitive to Poor Sleep: a Longitudinal Study Using Wearable Electroencephalography Devices

Epilepsy, a prevalent neurological disorder, affects 40% of patients with uncontrolled seizures despite medications. Sleep disturbance exacerbates epilepsy, an…

Epilepsy Intractable

Duke UniversityNCT06545643

Actual pay is set by the research site.

Evaluation of a Lupus Nephritis Care Pathway Integrating Telemedicine and Clinical Pharmacist Practitioners

The purpose of this study is to evaluate an approach to managing patients with lupus nephritis called the Lupus Nephritis (LN) Pathway among approximately 25 p…

Lupus Nephritis (LN)